Description
PRINCIPIO ACTIVO: ORLISTAT
Concentración: 6
No indicado en pacientes con hipoglucemia o hipersensibilidad conocida a los componentes
No indicado en pacientes con infecciones sistémicas no controladas o hipersensibilidad al medicamento
JGA DL 5ML 21X32 C5 FOSFATO DE SITAGLIPTINA PRINCIPIO ACTIVO: ORLISTATCaja C 5 Jeringas
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
